Internet Survey on Nutritional Management and Relapse Status in IBD Patients - 3R Survey

Internet Survey on Nutritional Management and Relapse Status in IBD Patients - 3R Survey - Internet Survey on Nutritional Management and Relapse Status in IBD Patients - 3R Survey

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000059440

Enrollment

150

Registered

2025-10-27

Start date

2025-11-04

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn&#39

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Individuals with Crohn's disease or ulcerative colitis who are registered in the Cross Marketing Co., Ltd. survey cooperation panel and who have agreed to participate in this survey

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Implementation rate of nutritional management and recurrence status, etc.	—

Secondary

Measure	Time frame
Disease, age, gender, height, weight, employment status, smoking status, outpatient visit frequency, duration of illness, surgical history, hospitalization history, severity of symptoms (diarrhea/abdominal pain), current medications, current treatment satisfaction, explanation of nutritional therapy, experience with Elental, current Elental usage (only for those with experience), changes after taking Elental (only for those with experience), duration of Elental use (only for those with experience), Reasons for discontinuing Enteral therapy (only for those with experience), frequency of IBD flare-ups, factors perceived to influence IBD flare-ups, dietary management status, supplement usage status, medication adherence, factors affecting missed doses, IBD health status, and use of nutrition management apps.	—

Measure

Time frame

Disease, age, gender, height, weight, employment status, smoking status, outpatient visit frequency, duration of illness, surgical history, hospitalization history, severity of symptoms (diarrhea/abdominal pain), current medications, current treatment satisfaction, explanation of nutritional therapy, experience with Elental, current Elental usage (only for those with experience), changes after taking Elental (only for those with experience), duration of Elental use (only for those with experience), Reasons for discontinuing Enteral therapy (only for those with experience), frequency of IBD flare-ups, factors perceived to influence IBD flare-ups, dietary management status, supplement usage status, medication adherence, factors affecting missed doses, IBD health status, and use of nutrition management apps.

—

Countries

Japan

Contacts

Public ContactTakahiro Suzuki

EA Pharma Medical Department, Medical Science Group

takahirob_suzuki@eapharma.co.jp080-1060-3254

Outcome results